Visionary Holdings Inc. Announces Resolution of Nasdaq Filing Deficiency and Confirmation of Continued Listing

Visionary Holdings (Nasdaq: GV) announced Nasdaq has closed a listing deficiency after the company filed its Annual Report on Form 20-F for the year ended March 31, 2025.

Rhea-AI Summary

Visionary Holdings (Nasdaq: GV) announced Nasdaq has closed a listing deficiency after the company filed its Annual Report on Form 20-F for the year ended March 31, 2025.

Visionary filed the Form 20-F on January 28, 2026; Nasdaq issued a compliance confirmation on January 29, 2026, confirming continued listing and closure of the matter.

Positive

• Nasdaq confirmed continued listing on January 29, 2026
• Form 20-F for fiscal year ended March 31, 2025 was filed January 28, 2026
• Company implemented procedural safeguards to prevent future filing delays

Negative

• None.

Argus Feb 4 session

-2.46% close to close Open Argus

Details

News Market Reaction – GV

In the Feb 4 session, GV declined 2.46%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement confirms that Visionary resolved its Nasdaq filing deficiency after submitting the...

Analysis

This announcement confirms that Visionary resolved its Nasdaq filing deficiency after submitting the delayed Form 20‑F for the year ended March 31, 2025, and that Nasdaq has closed the matter. The company attributes the delay to EDGAR authorization issues rather than financial or audit problems and notes new safeguards. In context of recent disclosures about strategic pivot and financial pressures, investors may focus on ongoing execution, governance standards, and future reporting timeliness as key markers to track.

Key Figures

Nasdaq rule: Listing Rule 5250(c)(1) Form 20-F year-end: March 31, 2025 Staff letter date: January 27, 2026 +3 more

Nasdaq rule

Listing Rule 5250(c)(1)

Periodic reporting compliance requirement referenced by Nasdaq

Form 20-F year-end

March 31, 2025

Fiscal year-end for the delayed Form 20-F

Staff letter date

January 27, 2026

Nasdaq Staff Determination Letter on filing deficiency

Filing completion date

January 28, 2026

Date Company completed and filed Form 20-F

Compliance confirmation date

January 29, 2026

Nasdaq letter confirming compliance and closing the matter

Filing deadline

January 26, 2026

Original deadline for Form 20-F cited in the article

Historical Context

5 past events · Latest: Feb 02

5 events

1. Feb 02

   Nasdaq compliance update

   24h Move

   +0.0%

   Announcement that Nasdaq confirmed regained compliance after Form 20-F filing.

2. Jan 20

   FY2025 correction update

   24h Move

   +2.5%

   Correction detailing FY2025 revenue decline, net loss, and negative working capital.

3. Jan 13

   FY2025 metrics correction

   24h Move

   +21.9%

   Finalized FY2025 report with steep revenue drop, losses, and liquidity pressures.

4. Jan 12

   FY2025 annual report

   24h Move

   -1.6%

   Annual report showing revenue down 46.2% YoY and substantial net loss.

5. Dec 30

   Governance and strategy

   24h Move

   -0.0%

   Governance changes and strategic pivot toward high-end medical aesthetics and AI.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nasdaq listing rule 5250(c)(1), form 20-f, edgar, listing qualifications department

4 terms

nasdaq listing rule 5250(c)(1) regulatory

"the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due"

Nasdaq Listing Rule 5250(c)(1) requires companies listed on the Nasdaq stock exchange to promptly notify the exchange if their stock price falls below a certain minimum level, known as the "initial listing standards." This rule helps ensure that investors are aware of significant declines in a company's stock value, which could signal financial trouble or increased risk. Essentially, it helps maintain transparency and protect investors by keeping them informed about important changes in a company's stock performance.

form 20-f regulatory

"delayed filing of its Annual Report on Form 20-F for the fiscal year ended"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

edgar technical

"technical delays related to the internal accreditation of administrative roles within the EDGAR system"

EDGAR is a system used by companies to share important financial and business information with the public. It functions like an online filing cabinet where investors can access official reports and documents that help them understand a company's financial health and operations. This transparency allows investors to make more informed decisions, much like checking a company's report card before investing.

listing qualifications department regulatory

"two formal communications from the Listing Qualifications Department of The Nasdaq Stock Market"

A listing qualifications department is the part of a stock exchange that checks whether a company meets the exchange’s rules for being listed and staying listed. Think of it as a gatekeeper or building inspector: it reviews financial statements, disclosure practices and corporate governance, flags problems and can require fixes or remove a company’s shares. Investors care because its decisions affect whether a stock remains tradable and how much trust to place in a company’s reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MARKHAM, Ontario, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (Nasdaq: GV) (the “Company”), a high-growth technology company specializing in innovative software solutions for the aesthetic medicine industry and cutting-edge advancements in stem cell research, today announced that it has received two formal communications from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) relating to the Company’s periodic reporting status.

On January 27, 2026, the Company received a Staff Determination Letter from Nasdaq indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 (the “Form 20-F”), and that, unless a hearing was timely requested, the Company’s securities would be subject to delisting.

In response, the Company promptly completed and filed its Form 20-F on January 28, 2026, resolving the only outstanding compliance issue. Although the report had been finalized and approved in advance of the January 26 deadline, technical delays related to the internal accreditation of administrative roles within the EDGAR system resulted in the filing being completed two days later than anticipated. On January 29, 2026, Nasdaq issued a compliance confirmation letter formally acknowledging that the Company now meets the requirements of Listing Rule 5250(c)(1) and that the matter is closed.

Frank Xiyong Hou, Chief Executive Officer of Visionary Holdings Inc., commented:

“We are pleased to have resolved this matter swiftly and to have received confirmation from Nasdaq that the Company remains in compliance with its continued listing obligations. While the delayed filing resulted from a technical issue involving EDGAR authorization and was not related to the Company’s financials or audit process, we take our disclosure responsibilities seriously and have implemented procedural safeguards to prevent recurrence.”

The Company remains focused on executing its strategic initiatives and maintaining the highest standards of financial reporting and corporate governance.

About Visionary Holdings Inc.
Visionary Holdings Inc., headquartered in Markham, Ontario, is a high-growth technology company specializing in innovative software solutions for the aesthetic medicine industry and cutting-edge advancements in stem cell research. By integrating cutting-edge technology with industrial resources, the Company aims to provide innovative solutions and high-quality services to a global market. Visionary Holdings continues to expand its footprint in the technology sector, seeking to deliver long-term value to its shareholders through strategic acquisitions and organic growth.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve predictions, expectations, or other information about future events, including the Company’s ability to maintain its Nasdaq listing. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those discussed. Factors that could cause such differences include, but are not limited to, market conditions and the Company's ability to execute its business strategy. The Company undertakes no obligation to update these statements, except as required by law.

Investor Relations & Media Contact:
Visionary Holdings Inc.
Email: ir@visionary.holdings

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Visionary Holdings (GV) receive a Nasdaq deficiency letter in January 2026?

The company received the letter for a delayed Form 20-F filing beyond the January 26 deadline. According to the company, technical EDGAR authorization delays caused the two-day late filing, not issues with financials or the audit process.

When did Visionary Holdings (GV) file the late Form 20-F for the fiscal year ended March 31, 2025?

Visionary filed the Form 20-F on January 28, 2026, resolving the filing deficiency. According to the company, the report was finalized earlier but EDGAR authorization delays postponed submission by two days.

What did Nasdaq do after Visionary Holdings (GV) filed the Form 20-F on January 28, 2026?

Nasdaq issued a compliance confirmation letter on January 29, 2026, closing the matter. According to the company, Nasdaq acknowledged the company now meets Listing Rule 5250(c)(1) requirements and the issue is resolved.

Does the filing delay affect Visionary Holdings (GV) financials or audits?

The company states the delay was technical and unrelated to its financial statements or audit process. According to the company, the late submission resulted from EDGAR authorization procedures, not from accounting or audit deficiencies.

How is Visionary Holdings (GV) preventing similar filing delays in the future?

Visionary implemented procedural safeguards to prevent recurrence of filing delays and strengthen disclosure controls. According to the company, these measures address EDGAR authorization steps and internal administrative accreditation processes.